End-to-end viral vector manufacturing services—from process development to GMP production for clinical and commercial programs.
Thermo Fisher Scientific’s viral vector CDMO services support the development and manufacturing of viral vectors for advanced therapeutics, including cell and gene therapies.
Our integrated capabilities span process development, analytical testing, and GMP manufacturing to help advance programs from early development through commercialization.
With more than 20 years of experience in the viral vector services space, we partner with biotech and pharmaceutical companies to deliver scalable, compliant manufacturing solutions.
This brochure provides detailed insight into our experience, capacity, and capabilities for viral vectors, including:
Download the brochure to see how our viral vector offerings help deliver breakthrough medicines to patients.